BCL7B anticorps
Aperçu rapide pour BCL7B anticorps (ABIN7111913)
Antigène
Voir toutes BCL7B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- BCL7B antibody
-
Purification
- Immunogen affinity purified
-
Pureté
- ≥95 % as determined by SDS-PAGE
-
Immunogène
- B-cell CLL/lymphoma 7B
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C for 12 months
-
Date de péremption
- 12 months
-
-
- BCL7B (B-Cell CLL/lymphoma 7B (BCL7B))
-
Autre désignation
- BCL7B
-
Sujet
-
Synonyms: B-cell CLL/lymphoma 7 protein family member B|BCL7B
Background: Positive regulator of apoptosis. Plays a role in the Wnt signaling pathway, negatively regulating the expression of Wnt signaling components CTNNB1 and HMGA1(PubMed:25569233). Involved in cell cycle progression, maintenance of the nuclear structure and stem cell differentiation(PubMed:25569233). May play a role in lung tumor development or progression(By similarity).
-
Poids moléculaire
- 45 kDa
-
ID gène
- 9275
-
UniProt
- Q9BQE9
Antigène
-